We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-16.51%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$9.93B
AUM Growth
-$3.38B
Cap. Flow
-$783M
Cap. Flow %
-7.89%
Top 10 Hldgs %
19.46%
Holding
2,102
New
46
Increased
519
Reduced
1,261
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 14.58%
2 Healthcare 9.97%
3 Financials 8.51%
4 Consumer Staples 6.67%
5 Consumer Discretionary 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFNC icon
1201
Simmons First National
SFNC
$3.4B
$774K 0.01%
42,083
-1,343
-3% -$30.5K
ROIC
1202
DELISTED
Retail Opportunity Investments Corp.
ROIC
$773K 0.01%
93,333
-350,136
-79% -$5.2M
MHK icon
1203
Mohawk Industries
MHK
$9.06B
$772K 0.01%
10,126
-3,969
-28% -$470K
HPS
1204
John Hancock Preferred Income Fund III
HPS
$459M
$771K 0.01%
56,424
+1,319
+2% +$23.4K
SPH icon
1205
Suburban Propane Partners
SPH
$1.19B
$768K 0.01%
54,311
+3,638
+7% +$70.7K
TKC icon
1206
Turkcell
TKC
$4.78B
$766K 0.01%
164,792
+31,732
+24% +$180K
TSCO icon
1207
Tractor Supply
TSCO
$17.9B
$763K 0.01%
45,120
-131,450
-74% -$2.36M
TTMI icon
1208
TTM Technologies
TTMI
$14B
$761K 0.01%
73,546
-2,096
-3% -$27.6K
ENTG icon
1209
Entegris
ENTG
$22.2B
$759K 0.01%
16,948
-9,734
-36% -$505K
ASB icon
1210
Associated Banc-Corp
ASB
$5.92B
$754K 0.01%
58,931
+5,966
+11% +$107K
FATE icon
1211
Fate Therapeutics
FATE
$325M
$752K 0.01%
33,868
+13,903
+70% +$352K
G icon
1212
Genpact
G
$5.75B
$752K 0.01%
25,731
-69,509
-73% -$2.72M
FLO icon
1213
Flowers Foods
FLO
$1.51B
$751K 0.01%
36,610
+4,692
+15% +$102K
SBNY
1214
DELISTED
Signature Bank
SBNY
$751K 0.01%
9,330
-324
-3% -$40.7K
OCSL icon
1215
Oaktree Specialty Lending
OCSL
$1.11B
$750K 0.01%
77,115
-8,330
-10% -$122K
ACIA
1216
DELISTED
Acacia Communications Inc
ACIA
$749K 0.01%
11,152
+2,994
+37% +$203K
HQY icon
1217
HealthEquity
HQY
$8.91B
$747K 0.01%
14,767
-4,035
-21% -$268K
THQ
1218
abrdn Healthcare Opportunities Fund
THQ
$804M
$746K 0.01%
48,578
+5,457
+13% +$96K
EQM
1219
DELISTED
EQM Midstream Partners, LP
EQM
$744K 0.01%
63,089
+12,901
+26% +$263K
IT icon
1220
Gartner
IT
$12B
$742K 0.01%
7,448
-1,154
-13% -$158K
RH icon
1221
RH
RH
$3.63B
$742K 0.01%
7,388
-181
-2% -$33.7K
RARX
1222
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$742K 0.01%
15,461
+3,853
+33% +$179K
ROL icon
1223
Rollins
ROL
$17.9B
$740K 0.01%
30,719
-6,486
-17% -$160K
SANM icon
1224
Sanmina
SANM
$10.9B
$740K 0.01%
27,114
-5,337
-16% -$156K
WTFC icon
1225
Wintrust Financial
WTFC
$10.7B
$736K 0.01%
22,417
-2,387
-10% -$132K

Similar funds

Guggenheim Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Guggenheim Capital held 2,102 positions worth $9.93B, down 25% from $13.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Guggenheim Capital withdrew a net $783M in Q1 2020, closing 268 positions and reducing 1,261 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $95.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Guggenheim Capital opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $255M.

  • Guggenheim Capital's largest Q1 2020 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 3,315,008 shares worth $255M.
  • Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2020, an estimated $736M increase.
  • Guggenheim Capital's biggest Q1 2020 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $255M.
  • Guggenheim Capital fully exited iShares Core S&P 500 ETF in Q1 2020, selling an estimated $95.7M.
  • Guggenheim Capital's ten largest holdings make up 19% of its $9.93B portfolio in Q1 2020.
  • Guggenheim Capital opened 46 new positions and closed 268 in Q1 2020.
  • Guggenheim Capital's portfolio value fell 25% quarter-over-quarter to $9.93B.

Based on Guggenheim Capital's 13F filing for Q1 2020, filed 2 Jun 2020.